Steven E. Arnold, MD - Related publications

Affiliations: 
Center for Neurobiology and Behavior University of Pennsylvania, Philadelphia, PA, United States 
Area:
Cellular and molecular neurobiology of schizophrenia and mood disorders, aging and neurodegenerative dementias
Website:
http://www.med.upenn.edu/ins/faculty/arnold.htm
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Uysal G, Ozturk M. Hippocampal atrophy based Alzheimer's disease diagnosis via machine learning methods. Journal of Neuroscience Methods. 337: 108669. PMID 32126274 DOI: 10.1016/j.jneumeth.2020.108669   
2020 Bogdanovic N, Hansson O, Zetterberg H, Basun H, Ingelsson M, Lannfelt L, Blennow K. [Alzheimer's disease - the most common cause of dementia]. Lakartidningen. 117. PMID 32154904   
2020 Szegedi S, Dal-Bianco P, Stögmann E, Traub-Weidinger T, Rainer M, Masching A, Schmidl D, Werkmeister RM, Chua J, Schmetterer L, Garhöfer G. Anatomical and functional changes in the retina in patients with Alzheimer's disease and mild cognitive impairment. Acta Ophthalmologica. PMID 32212415 DOI: 10.1111/aos.14419   
2020 Ye LQ, Li XY, Zhang YB, Cheng HR, Ma Y, Chen DF, Tao QQ, Li HL, Wu ZY. The discriminative capacity of CSF β-amyloid 42 and Tau in neurodegenerative diseases in the Chinese population. Journal of the Neurological Sciences. 412: 116756. PMID 32142967 DOI: 10.1016/j.jns.2020.116756   
2020 Wilson EN, Swarovski MS, Linortner P, Shahid M, Zuckerman AJ, Wang Q, Channappa D, Minhas PS, Mhatre SD, Plowey ED, Quinn JF, Zabetian CP, Tian L, Longo FM, Cholerton B, et al. Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau. Brain : a Journal of Neurology. PMID 32065223 DOI: 10.1093/brain/awaa021   
2020 Oeckl P, Halbgebauer S, Anderl-Straub S, von Arnim CAF, Diehl-Schmid J, Froelich L, Grimmer T, Hausner L, Denk J, Jahn H, Steinacker P, Weishaupt JH, Ludolph AC, Otto M. Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer's Disease. Journal of Proteome Research. 19: 1310-1318. PMID 32101007 DOI: 10.1021/acs.jproteome.9b00824   
2020 Verny M, Duyckaerts C. Cognitive deficit, and neuropathological correlates, in the oldest-old. Revue Neurologique. PMID 32178879 DOI: 10.1016/j.neurol.2020.01.355   
2020 Li X, Xiong Z, Liu Y, Yuan Y, Deng J, Xiang W, Li Z. Case report of first-episode psychotic symptoms in a patient with early-onset Alzheimer's disease. Bmc Psychiatry. 20: 128. PMID 32183776 DOI: 10.1186/s12888-020-02537-9   
2020 Jääskeläinen O, Hall A, Tiainen M, van Gils M, Lötjönen J, Kangas AJ, Helisalmi S, Pikkarainen M, Hallikainen M, Koivisto A, Hartikainen P, Hiltunen M, Ala-Korpela M, Soininen P, Soininen H, et al. Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32007958 DOI: 10.3233/JAD-191226   
2020 Polis B, Samson AO. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders. Neural Regeneration Research. 15: 1460-1470. PMID 31997805 DOI: 10.4103/1673-5374.274328   
2020 Okafor M, Nye JA, Shokouhi M, Shaw L, Goldstein F, Hajjar I. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32065800 DOI: 10.3233/JAD-191330   
2020 Vignoli A, Paciotti S, Tenori L, Eusebi P, Biscetti L, Chiasserini D, Scheltens P, Turano P, Teunissen C, Luchinat C, Parnetti L. Fingerprinting Alzheimer's Disease by H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid. Journal of Proteome Research. PMID 32118444 DOI: 10.1021/acs.jproteome.9b00850   
2020 Terrera GM, Harrison JE, Ritchie CW, Ritchie K. Cognitive Functions as Predictors of Alzheimer's Disease Biomarker Status in the European Prevention of Alzheimer's Dementia Cohort. Journal of Alzheimer's Disease : Jad. PMID 32144988 DOI: 10.3233/JAD-191108   
2020 Weigand AJ, Bangen KJ, Thomas KR, Delano-Wood L, Gilbert PE, Brickman AM, Bondi MW, . Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity. Brain Communications. 2: fcz046. PMID 32051933 DOI: 10.1093/braincomms/fcz046   
2020 Cortes-Canteli M, Iadecola C. Alzheimer's Disease and Vascular Aging: JACC Focus Seminar. Journal of the American College of Cardiology. 75: 942-951. PMID 32130930 DOI: 10.1016/j.jacc.2019.10.062   
2020 Yan S, Zheng C, Cui B, Qi Z, Zhao Z, An Y, Qiao L, Han Y, Zhou Y, Lu J. Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32157432 DOI: 10.1007/s00259-020-04752-8   
2020 Pichet Binette A, Vachon-Presseau É, Morris J, Bateman R, Benzinger T, Collins DL, Poirier J, Breitner JCS, Villeneuve S, , . Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease. Biological Psychiatry. PMID 32228870 DOI: 10.1016/j.biopsych.2020.01.023   
2020 Rashid MH, Zahid MF, Zain S, Kabir A, Hassan SU. The Neuroprotective Effects of Exercise on Cognitive Decline: A Preventive Approach to Alzheimer Disease. Cureus. 12: e6958. PMID 32190507 DOI: 10.7759/cureus.6958   
2020 Hameed S, Fuh JL, Senanarong V, Ebenezer EGM, Looi I, Dominguez JC, Park KW, Karanam AK, Simon O. Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer's Disease. Journal of Alzheimer's Disease Reports. 4: 21-37. PMID 32206755 DOI: 10.3233/ADR-190143   
2020 Dhiman K, Gupta VB, Villemagne VL, Eratne D, Graham PL, Fowler C, Bourgeat P, Li QX, Collins S, Bush AI, Rowe CC, Masters CL, Ames D, Hone E, Blennow K, et al. Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12005. PMID 32211500 DOI: 10.1002/dad2.12005   
2020 Feng Q, Ding Z. MRI Radiomics Classification and Prediction in Alzheimer's Disease and Mild Cognitive Impairment: A Review. Current Alzheimer Research. PMID 32124697 DOI: 10.2174/1567205017666200303105016   
2020 Koychev I, Vaci N, Bilgel M, An Y, Muniz GT, Wong DF, Gallacher J, Mogekhar A, Albert M, Resnick SM. Prediction of rapid amyloid and phospotylated-Tau accumulation in cognitively healthy individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12019. PMID 32211504 DOI: 10.1002/dad2.12019   
2020 Insel PS, Mormino EC, Aisen PS, Thompson WK, Donohue MC. Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention. Brain Communications. 2: fcaa007. PMID 32140682 DOI: 10.1093/braincomms/fcaa007   
2020 Zhang C, Kong M, Wei H, Zhang H, Ma G, Ba M, . The effect of ApoE ε 4 on clinical and structural MRI markers in prodromal Alzheimer's disease. Quantitative Imaging in Medicine and Surgery. 10: 464-474. PMID 32190571 DOI: 10.21037/qims.2020.01.14   
2020 Sharma P, Sharma A, Fayaz F, Wakode S, Pottoo FH. Biological signatures of Alzheimer Disease. Current Topics in Medicinal Chemistry. PMID 32108008 DOI: 10.2174/1568026620666200228095553   
2020 Yan J, Raja V V, Huang Z, Amico E, Nho K, Fang S, Sporns O, Wu YC, Saykin A, Goni J, Shen L, . Brain-wide structural connectivity alterations under the control of Alzheimer risk genes. International Journal of Computational Biology and Drug Design. 13: 58-70. PMID 32095160 DOI: 10.1504/ijcbdd.2020.10026789   
2020 Cannavo C, Tosh J, Fisher EMC, Wiseman FK. Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21. Progress in Brain Research. 251: 181-208. PMID 32057307 DOI: 10.1016/bs.pbr.2019.10.004   
2020 Bawa KK, Krance SH, Herrmann N, Cogo-Moreira H, Ouk M, Yu D, Wu CY, Black SE, Lanctôt KL, Swardfager W, . A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease. Journal of Neuroinflammation. 17: 84. PMID 32171317 DOI: 10.1186/s12974-020-01750-3   
2020 Peng YS, Tang CW, Peng YY, Chang H, Chen CL, Guo SL, Wu LC, Huang MC, Lee HC. Comparative functional genomic analysis of Alzheimer's affected and naturally aging brains. Peerj. 8: e8682. PMID 32219020 DOI: 10.7717/peerj.8682   
2020 Habes M, Grothe MJ, Tunc B, McMillan C, Wolk DA, Davatzikos C. Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods. Biological Psychiatry. PMID 32201044 DOI: 10.1016/j.biopsych.2020.01.016   
2020 Dallé E, Mabandla MV, Daniels WMU. Dielectric Constant and Conductivity of Blood Plasma: Possible Novel Biomarkers for Alzheimer's Disease. Oxidative Medicine and Cellular Longevity. 2020: 5756382. PMID 32148652 DOI: 10.1155/2020/5756382   
2020 Christensen KD, Karlawish J, Roberts JS, Uhlmann WR, Harkins K, Wood EM, Obisesan TO, Le LQ, Cupples LA, Zoltick ES, Johnson MS, Bradbury MK, Waterston LB, Chen CA, Feldman S, ... , et al. Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment. Alzheimer's & Dementia (New York, N. Y.). 6: e12002. PMID 32211507 DOI: 10.1002/trc2.12002   
2020 Ossenkoppele R, Lyoo CH, Jester-Broms J, Sudre CH, Cho H, Ryu YH, Choi JY, Smith R, Strandberg O, Palmqvist S, Kramer J, Boxer AL, Gorno-Tempini ML, Miller BL, La Joie R, et al. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease. Jama Neurology. PMID 32091549 DOI: 10.1001/jamaneurol.2019.5154   
2020 Gold D, Rosowsky E, Piryatinsky I, Sinclair SJ. Comparing patient and informant ratings of depressive symptoms in various stages of Alzheimer's disease. Neuropsychology. PMID 32191055 DOI: 10.1037/neu0000630   
2020 Yan Y, Yang H, Xie Y, Ding Y, Kong D, Yu H. Research Progress on Alzheimer's Disease and Resveratrol. Neurochemical Research. PMID 32162143 DOI: 10.1007/s11064-020-03007-0   
2020 Whitwell JL, Tosakulwong N, Weigand SD, Graff-Radford J, Duffy JR, Clark HM, Machulda MM, Botha H, Utianski RL, Schwarz CG, Senjem ML, Strand EA, Ertekin-Taner N, Jack CR, Lowe VJ, et al. Longitudinal Amyloid-β PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration. Journal of Alzheimer's Disease : Jad. PMID 32039841 DOI: 10.3233/JAD-190699   
2020 Lamballais S, Muetzel RL, Ikram MA, Tiemeier H, Vernooij MW, White T, Adams HHH. Genetic Burden for Late-Life Neurodegenerative Disease and Its Association With Early-Life Lipids, Brain, Behavior, and Cognition. Frontiers in Psychiatry. 11: 33. PMID 32116848 DOI: 10.3389/fpsyt.2020.00033   
2020 Upadhyaya Y, Xie L, Salama P, Cao S, Nho K, Saykin AJ, Yan J, Alzheimer's Disease Neuroimaging Initiative FT. Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer's disease. Bmc Medical Genomics. 13: 53. PMID 32241275 DOI: 10.1186/s12920-020-0689-y   
2020 Chiu MJ, Chen TF, Hu CJ, Yan SH, Sun Y, Liu BH, Chang YT, Yang CC, Yang SY. Nannoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease - A cross-validation study. Nanomedicine : Nanotechnology, Biology, and Medicine. 102182. PMID 32222476 DOI: 10.1016/j.nano.2020.102182   
2020 Serrano GE, Shprecher D, Callan M, Cutler B, Glass M, Zhang N, Walker J, Intorcia A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Belden CM, Zamrini E, Sue LI, et al. Cardiac sympathetic denervation and synucleinopathy in Alzheimer's disease with brain Lewy body disease. Brain Communications. 2: fcaa004. PMID 32064463 DOI: 10.1093/braincomms/fcaa004   
2020 Cai H, Ning S, Li W, Li X, Xiao S, Sun L. Patient with frontal-variant syndrome in early-onset Alzheimer's disease. General Psychiatry. 33: e100173. PMID 32215362 DOI: 10.1136/gpsych-2019-100173   
2020 Sims R, Hill M, Williams J. The multiplex model of the genetics of Alzheimer's disease. Nature Neuroscience. PMID 32112059 DOI: 10.1038/s41593-020-0599-5   
2020 Kleineidam L, Chouraki V, Próchnicki T, van der Lee SJ, Madrid-Márquez L, Wagner-Thelen H, Karaca I, Weinhold L, Wolfsgruber S, Boland A, Martino Adami PV, Lewczuk P, Popp J, Brosseron F, Jansen IE, ... , et al. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathologica. PMID 32166339 DOI: 10.1007/s00401-020-02138-6   
2020 Hsieh SW, Huang LC, Chang YP, Hung CH, Yang YH. M2b Macrophage Subset Decrement as an Indicator of Cognitive Function in Alzheimer's Disease. Psychiatry and Clinical Neurosciences. PMID 32170772 DOI: 10.1111/pcn.13000   
2020 de Wolf F, Ghanbari M, Licher S, McRae-McKee K, Gras L, Weverling GJ, Wermeling P, Sedaghat S, Ikram MK, Waziry R, Koudstaal W, Klap J, Kostense S, Hofman A, Anderson R, et al. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study. Brain : a Journal of Neurology. PMID 32206776 DOI: 10.1093/brain/awaa054   
2020 Largent EA, Harkins K, van Dyck CH, Hachey S, Sankar P, Karlawish J. Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results. Plos One. 15: e0229137. PMID 32053667 DOI: 10.1371/journal.pone.0229137   
2020 Ranasinghe KG, Cha J, Iaccarino L, Hinkley LB, Beagle AJ, Pham J, Jagust WJ, Miller BL, Rankin KP, Rabinovici GD, Vossel KA, Nagarajan SS. Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline. Science Translational Medicine. 12. PMID 32161102 DOI: 10.1126/scitranslmed.aaz4069   
2020 Curiel Cid RE, Crocco EA, Duara R, Garcia JM, Rosselli M, DeKosky ST, Smith G, Bauer R, Chirinos CL, Adjouadi M, Barker W, Loewenstein DA. A novel method of evaluating semantic intrusion errors to distinguish between amyloid positive and negative groups on the Alzheimer's disease continuum. Journal of Psychiatric Research. 124: 131-136. PMID 32146222 DOI: 10.1016/j.jpsychires.2020.02.008   
2020 Tadayon E, Pascual-Leone A, Press D, Santarnecchi E, . Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer's and Parkinson's disease. Neurobiology of Aging. PMID 32107064 DOI: 10.1016/j.neurobiolaging.2020.01.005   
2020 Schrank S, McDaid J, Briggs CA, Mustaly-Kalimi S, Brinks D, Houcek A, Singer O, Bottero V, Marr RA, Stutzmann GE. Human-Induced Neurons from Presenilin 1 Mutant Patients Model Aspects of Alzheimer's Disease Pathology. International Journal of Molecular Sciences. 21. PMID 32033164 DOI: 10.3390/ijms21031030